TERT and breast cancer: Second, TERT and HRAS mutations have been shown to be vanishingly rare in primary breast cancers, including those of triple-negative phenotype; however, these alterations can be found in adenomyoepitheliomas and in a subset of MBCs, suggesting a tantalizing hypothesis that a subset of MBCs may evolve through similar genetic pathways or be etiologically related to adenomyoepithelial tumors.